tiprankstipranks
Trending News
More News >
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Revenue

Compare
3,428 Followers

Editas Medicine Revenue

Editas Medicine had a revenue of 30.60M in the quarter ending Dec 31, 2024, with 50070.49%. This bring the company's revenue in the last twelve months to 32.31M, Increased -47.68%. In the fiscal year ending Dec 31, 2024, Editas Medicine had annual revenue of 32.31M with -58.64% growth.
Revenue (ttm)
32.31M
Revenue Growth
-58.64%
P/S Ratio
3.42
Revenue/Employee
$131,358
Employees
246
Market Cap
$110.50M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 202432.31M-45.81M-58.64%
Dec 31, 202378.12M58.41M+296.32%
Dec 31, 202219.71M-5.83M-22.83%
Dec 31, 202125.54M-65.19M-71.85%
Dec 31, 202090.73M70.20M+341.93%
Dec 31, 201920.53M-11.41M-35.71%
Dec 31, 201831.94M18.21M+132.64%
Dec 31, 201713.73M7.67M+126.80%
Dec 31, 20166.05M4.42M+271.58%
Dec 31, 20151.63M+∞%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis